Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06729164 · ClinicalTrials.gov registry record · NA
Strategic and Interactive Signing Instruction Experiment
A NA study of Sign Language Skills and Teacher Practice, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06729164 is a NA study of Sign Language Skills and Teacher Practice that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06729164, a NA study of Sign Language Skills and Teacher Practice, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.
Conditions Studied
Interventions
- BEHAVIORAL Strategic and Interactive Signing Instruction
- BEHAVIORAL Business-As-Usual Instruction
Study Locations (1)
Tennessee
- University of Tennessee, Knoxville - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06729164
The ClinicalTrials.gov registry entry for NCT06729164 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sign Language Skills appearing as the primary indexed condition, and to 2 interventions - of which Strategic and Interactive Signing Instruction is the first listed.
NCT06729164 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06729164 about?
NCT06729164 is a clinical study titled "Strategic and Interactive Signing Instruction Experiment". This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. ...
What is the current status of trial NCT06729164?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2026-07-30.
What conditions does trial NCT06729164 study?
This clinical trial studies the following conditions: Sign Language Skills, Teacher Practice.
What interventions are being tested in trial NCT06729164?
The interventions under investigation include: Strategic and Interactive Signing Instruction (BEHAVIORAL), Business-As-Usual Instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06729164?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06729164 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sign Language Skills
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.